StockData
Strata Critical Medical, Inc. logo

Strata Critical Medical, Inc. (SRTA) stock

SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3050% below fair value
$5.42−0.09 (-1.63%)

Close on Nov 16, 2026Market cap $479.49MP/E 10.6Yield –

Strata Critical Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Strata Critical Medical's price to sales ratio was 2.0× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.9× to 7.5×, with a median of 2.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×−0.3
2025Dec 31, 20252.3×+0.7
2024Dec 31, 20241.6×−1.4
2023Dec 29, 20233.0×−0.0
2022Dec 30, 20223.0×−4.5
2021Dec 31, 20217.5×−4.4
2020Dec 31, 202011.9×–

More Strata Critical Medical figures

See a number that looks wrong?